Clinical CRO Market Size Report 2023-2030 - Benzinga
| 300404 Stock | 9.27 0.01 0.11% |
About 53% of Guangzhou Boji's investor base is interested to short. The analysis of overall sentiment of trading Guangzhou Boji Medical stock suggests that many investors are impartial at this time. The current market sentiment, together with Guangzhou Boji's historical and current headlines, can help investors time the market. In addition, many technical investors use Guangzhou Boji Medical stock news signals to limit their universe of possible portfolio assets.
Guangzhou |
Clinical CRO Market Size Report 2023-2030 Benzinga
Read at news.google.com
 |
Guangzhou Boji Fundamental Analysis
We analyze Guangzhou Boji's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Guangzhou Boji using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Guangzhou Boji based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Retained Earnings
Retained Earnings Comparative Analysis
Guangzhou Boji is currently under evaluation in retained earnings category among its peers. Retained Earnings is a balance sheet account that refers to the portion of company income that is retained by the firm. In other words, it is a part of earnings that is not paid out as dividends or otherwise distributed to owners. Retained Earnings are calculated by adding net income to last period retained earnings and subtracting any dividends paid to owners.
Guangzhou Boji Medical Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Guangzhou Boji stock to make a market-neutral strategy. Peer analysis of Guangzhou Boji could also be used in its relative valuation, which is a method of valuing Guangzhou Boji by comparing valuation metrics with similar companies.
Peers
Guangzhou Boji Related Equities
| 200596 | Anhui Gujing | 0.46 | ||||
| 600519 | Kweichow Moutai | 0.11 | ||||
| 002594 | BYD Co | 0.09 | ||||
| 688169 | Beijing Roborock | 0.01 | ||||
| 300750 | Contemporary Amperex | 0.13 | ||||
| 000596 | Anhui Gujing | 0.92 | ||||
| 300760 | Shenzhen Mindray | 0.95 | ||||
| 603444 | G Bits | 1.39 | ||||
| 002371 | NAURA Technology | 3.93 |
Complementary Tools for Guangzhou Stock analysis
When running Guangzhou Boji's price analysis, check to measure Guangzhou Boji's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Guangzhou Boji is operating at the current time. Most of Guangzhou Boji's value examination focuses on studying past and present price action to predict the probability of Guangzhou Boji's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Guangzhou Boji's price. Additionally, you may evaluate how the addition of Guangzhou Boji to your portfolios can decrease your overall portfolio volatility.
| Stocks Directory Find actively traded stocks across global markets | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |